Cargando…

Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers

PURPOSE: High-risk human papillomaviruses (HR HPV) cause cervical cancer, and in these cancers, HPV type 16 is the most common HR type. The HR viral oncogenes E6 and E7 partner with cellular proteins to drive cancer and modulate immune pathways; previously, we demonstrated in keratinocytes that HPV...

Descripción completa

Detalles Bibliográficos
Autores principales: Chintala, Sreenivasulu, Levan, Justine, Robinson, Kristin, Quist, Kevin, Katzenellenbogen, Rachel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326398/
https://www.ncbi.nlm.nih.gov/pubmed/32617009
http://dx.doi.org/10.2147/OTT.S251926
_version_ 1783552333554122752
author Chintala, Sreenivasulu
Levan, Justine
Robinson, Kristin
Quist, Kevin
Katzenellenbogen, Rachel A
author_facet Chintala, Sreenivasulu
Levan, Justine
Robinson, Kristin
Quist, Kevin
Katzenellenbogen, Rachel A
author_sort Chintala, Sreenivasulu
collection PubMed
description PURPOSE: High-risk human papillomaviruses (HR HPV) cause cervical cancer, and in these cancers, HPV type 16 is the most common HR type. The HR viral oncogenes E6 and E7 partner with cellular proteins to drive cancer and modulate immune pathways; previously, we demonstrated in keratinocytes that HPV 16 E6 and high expression of the endogenous host protein partner NFX1-123 led to the increased expression of multiple genes, including Notch1, secretory leukocyte peptidase inhibitor (SLPI), and retinoic acid early transcript 1G (RAET1G). The present study was conducted to determine if NFX1-123 was highly expressed in cervical cancer and if genes increased by NFX1-123 and 16E6 in keratinocytes were also increased in cervical cancers. MATERIALS AND METHODS: The Cancer Genome Atlas (TCGA) database and The Human Protein Atlas database were used to compare relative mRNA and protein gene expression, respectively, in the normal cervix and cervical cancers. Formalin-fixed paraffin-embedded (FFPE) normal cervix and HPV 16 positive cervical cancer samples were analyzed for relative protein expression by immunohistochemical staining. Protein expression of a subset of regulated genes was quantified by Western blot of HPV positive and negative cell lines. RESULTS: Immunohistochemical staining of HPV 16 positive cervical dysplasias and cancers revealed high NFX1-123, Ki67, and Notch1 expression. NFX1 and NFX1L1 mRNA levels were increased in cervical cancers compared to normal cervix in the TCGA database. Fourteen genes previously identified as upregulated in keratinocytes with 16E6 and overexpressed NFX1-123 also had high mRNA expression and selected genes had high protein expression in cervical cancers and cell lines. CONCLUSION: In cervical cancer, NFX1-123 is highly expressed, and 16E6 and NFX1-123 together alter the expression of a wide set of genes. The involvement of these genes in cell proliferation, differentiation, invasion, and metastasis provides further insight into potential ways that HR HPVs promote cancer initiation and maintenance.
format Online
Article
Text
id pubmed-7326398
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73263982020-07-01 Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers Chintala, Sreenivasulu Levan, Justine Robinson, Kristin Quist, Kevin Katzenellenbogen, Rachel A Onco Targets Ther Original Research PURPOSE: High-risk human papillomaviruses (HR HPV) cause cervical cancer, and in these cancers, HPV type 16 is the most common HR type. The HR viral oncogenes E6 and E7 partner with cellular proteins to drive cancer and modulate immune pathways; previously, we demonstrated in keratinocytes that HPV 16 E6 and high expression of the endogenous host protein partner NFX1-123 led to the increased expression of multiple genes, including Notch1, secretory leukocyte peptidase inhibitor (SLPI), and retinoic acid early transcript 1G (RAET1G). The present study was conducted to determine if NFX1-123 was highly expressed in cervical cancer and if genes increased by NFX1-123 and 16E6 in keratinocytes were also increased in cervical cancers. MATERIALS AND METHODS: The Cancer Genome Atlas (TCGA) database and The Human Protein Atlas database were used to compare relative mRNA and protein gene expression, respectively, in the normal cervix and cervical cancers. Formalin-fixed paraffin-embedded (FFPE) normal cervix and HPV 16 positive cervical cancer samples were analyzed for relative protein expression by immunohistochemical staining. Protein expression of a subset of regulated genes was quantified by Western blot of HPV positive and negative cell lines. RESULTS: Immunohistochemical staining of HPV 16 positive cervical dysplasias and cancers revealed high NFX1-123, Ki67, and Notch1 expression. NFX1 and NFX1L1 mRNA levels were increased in cervical cancers compared to normal cervix in the TCGA database. Fourteen genes previously identified as upregulated in keratinocytes with 16E6 and overexpressed NFX1-123 also had high mRNA expression and selected genes had high protein expression in cervical cancers and cell lines. CONCLUSION: In cervical cancer, NFX1-123 is highly expressed, and 16E6 and NFX1-123 together alter the expression of a wide set of genes. The involvement of these genes in cell proliferation, differentiation, invasion, and metastasis provides further insight into potential ways that HR HPVs promote cancer initiation and maintenance. Dove 2020-06-26 /pmc/articles/PMC7326398/ /pubmed/32617009 http://dx.doi.org/10.2147/OTT.S251926 Text en © 2020 Chintala et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Chintala, Sreenivasulu
Levan, Justine
Robinson, Kristin
Quist, Kevin
Katzenellenbogen, Rachel A
Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers
title Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers
title_full Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers
title_fullStr Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers
title_full_unstemmed Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers
title_short Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers
title_sort genes regulated by hpv 16 e6 and high expression of nfx1-123 in cervical cancers
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326398/
https://www.ncbi.nlm.nih.gov/pubmed/32617009
http://dx.doi.org/10.2147/OTT.S251926
work_keys_str_mv AT chintalasreenivasulu genesregulatedbyhpv16e6andhighexpressionofnfx1123incervicalcancers
AT levanjustine genesregulatedbyhpv16e6andhighexpressionofnfx1123incervicalcancers
AT robinsonkristin genesregulatedbyhpv16e6andhighexpressionofnfx1123incervicalcancers
AT quistkevin genesregulatedbyhpv16e6andhighexpressionofnfx1123incervicalcancers
AT katzenellenbogenrachela genesregulatedbyhpv16e6andhighexpressionofnfx1123incervicalcancers